TrialPathology oncology research : POR2021

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.

Zoltán Lőcsei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.